Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo. (Q51550263)
Jump to navigation
Jump to search
scientific article published on 23 January 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo. |
scientific article published on 23 January 2005 |
Statements
Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo (English)
Jianghong Jiang
Rana A K Singh
Weitao Song
Michael Barry
Mary H Huls
Kevin M Slawin
David M Spencer
23 January 2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference